Health News - Diabetic Life. Learn about Juvenile Diabetes, Heart Disease, Glucose testing and much more.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Glucose 'Tattoo' Could Track Blood Sugar Levels for Diabetics

Device includes 'carbon nanotubes' injected under skin, say researchers

By Serena Gordon
HealthDay Reporter

FRIDAY, June 4 (HealthDay News) -- In the future, people with diabetes may be able to monitor their blood sugar levels using a glucose "tattoo."

This new type of continuous glucose monitor relies on fluorescent nanoparticle ink injected under the skin to detect blood sugar levels with a watch-sized or smaller monitor worn over the skin, according to the researchers at the Massachusetts Institute of Technology (MIT) who are developing the new technology.

Advertisement
Related Stories
 border=
Dementia Warning Signs Identified in Type 2 Diabetics: Study
Immune System Genes Show Links to Type 1 Diabetes
Mouse Study May Help Explain Fish Oil's Benefits
Related Videos
 border=
Removing Tumors Through the Nose
Kids Diagnosing Themselves
Reversing Nerve Damage
Related Slides
 border=
Diabetes
Thyroid Disease
Diabetic Retinopathy
Related Encyclopedia
 border=
Addison's Disease
Carcinoid Syndrome
Congenital Adrenal Hyperplasia


The glucose "tattoo" ink would be made from carbon nanotubes that can reflect infrared light back through the skin to the monitor, and this new device has the potential to free people with diabetes from having to do numerous finger pricks each day or to change a continuous glucose monitor device every three to seven days to keep track of their blood sugar levels.

"Carbon nanotubes will fluoresce in infrared light, and we can decorate the tubes so they fluoresce in response to glucose," explained senior researcher Michael Strano, the Charles and Hilda Roddey associate professor of chemical engineering at MIT.

"When you shine a light on the nanotubes, they'll shine light back at a different wavelength to a watch-type diode that could tell how much glucose is around," said Strano.

He said that the actual monitor that's worn over the skin would probably be watch-sized or smaller, depending on the size of the batteries. "If technology keeps shrinking at the current rate, it will probably be smaller than a watch," he said.

Currently, most people with type 1 diabetes have to prick their fingers up to a dozen times a day to assess their blood sugar levels. The newest technology -- continuous glucose monitoring -- involves placing a small glucose sensor that's implanted into the skin, and must be replaced every three to seven days. These devices also must be calibrated daily using a finger stick at least several times a day. The biggest advantage these devices offer is they let someone with diabetes know whether their blood sugar levels are trending up or down.

The reason this is important is that people with type 1 diabetes have to try to maintain as normal blood sugar levels as possible. If blood sugar levels go too low, people with diabetes can go into a coma, and can even die if they don't do something to raise their blood sugar levels. And, if blood sugar levels are too high, many areas in the body, including the eyes, kidneys and the heart, can be damaged.

"Most of the damage diabetes does occurs over short time periods where glucose is spiking and going out of the normal range. If you could intervene and prevent these spikes, you could mitigate many of the effects of this damaging disease," said Strano.

Strano said the researchers are currently trying the nanoparticles in animals, and so don't yet know what side effects or allergic reactions might occur. "We're proceeding in a cautious way," he said.

"Everybody is looking for a painless way to monitor blood sugar, and this technology sounds good, but I have no idea if it's going to work or not. From here to reality will take a lot of steps and research," said Dr. Joel Zonszein, director of the clinical diabetes center at Montefiore Medical Center in New York City.

Plus, he said, there's always the possibility of an adverse reaction to anything placed inside the body. "Our cells don't like foreign bodies. Already, immune cells very carefully try to reject the continuous glucose monitor sensor and fibrose [form scar tissue] around it," he said.

More information

To learn more about the current advances in continuous glucose monitoring, visit the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.

SOURCES: Michael Strano, Ph.D., Charles and Hilda Roddey associate professor of chemical engineering, Massachusetts Institute of Technology, Cambridge, Mass.; Joel Zonszein, M.D., professor, clinical medicine, and director, clinical diabetes center, Montefiore Medical Center and Albert Einstein College of Medicine, New York City

Copyright © 2010 HealthDay. All rights reserved.
Last updated 6/4/2010



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Sep 9, 2010
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Diabetes Connections
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: